17/07/2025 15:20 Russia launches massive attacks; Trump backtracks from suggestion Ukraine should target Moscow
17/07/2025 15:20 Vance hits the road to tout passage of GOP megabill
17/07/2025 15:20 Mike Johnson calls for Epstein files and ICE memos gives deportation guidance: Morning Rundown
17/07/2025 13:21 Senate sends bill axing foreign aid, public broadcast funds to House
17/07/2025 13:21 Lily James explores an actor’s loneliness in ‘Finally Dawn’
17/07/2025 13:21 South Korea’s top court acquits Samsung chief of fraud charges
17/07/2025 11:20 Do women really need more sleep than men? A sleep psychologist explains
17/07/2025 11:20 Inside Apple’s $500 million bet on U.S. rare earths
17/07/2025 11:20 How companies can support Indigenous communities in carbon markets
17/07/2025 09:20 Tips to Avoid Over Compaction in Construction

KalVista Secures UK Approval For EKTERLY, First Oral On-Demand Treatment For Hereditary Angioedema

Home » Travel » United States » KalVista Secures UK Approval For EKTERLY, First Oral On-Demand Treatment For Hereditary Angioedema

KalVista Secures UK Approval For EKTERLY, First Oral On-Demand Treatment For Hereditary Angioedema

RTTNews 16/07/2025 07:34

RTTNews) – KalVista Pharmaceuticals Inc. (KALV) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) has granted marketing authorization for EKTERLY (sebetralstat), a novel plasma kallikrein inhibitor, for the treatment of here…

Nasdaq
RTTNews) – KalVista Pharmaceuticals Inc. (KALV) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) of the United Kingdom (UK) has granted marketing authorization for EKTERLY (sebetralstat), a novel plasma kallikrein inhibitor, for the treatment of here…
Read More

KalVista Secures UK Approval For EKTERLY, First Oral On-Demand Treatment For Hereditary Angioedema

Syria’s president accuses Israel of ‘trying to drag us into war’

Syria Vows to Protect Druze Amid Israeli Threats

ICC Declines Israel’s Bid to Halt Netanyahu Arrest Warrant

Services

About

This website uses cookies to ensure you get the best experience on our website.